Stay updated on Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page’s revision tag has been updated to Revision: v3.6.4, and the previous Revision: v3.6.3 tag has been removed. This represents a new version of the page without changes to the core study content.
    Difference
    0.0%
    Check dated 2026-07-27T06:16:20.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.3, indicating a newer version of the page or template. This change does not alter the study details, eligibility criteria, or outcomes presented on the page.
    Difference
    0.0%
    Check dated 2026-07-05T13:35:37.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now displays 'No longer looking for participants,' indicating that recruitment for the study has closed.
    Difference
    0.4%
    Check dated 2026-06-14T03:59:34.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces v3.5.4, indicating a new page build; the study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-06T23:39:15.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.4, replacing the previous v3.5.3, indicating a new build of the page.
    Difference
    0.0%
    Check dated 2026-05-16T09:07:15.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    The page’s footer version/release label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a site software update without changing the clinical trial information displayed.
    Difference
    0.0%
    Check dated 2026-04-25T05:22:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page.